Genetics and epidemiology of multiple sclerosis

CONTINUUM Lifelong Learning in Neurology

Volumn 13, Issue 5 MULTIPL.SCLEROSIS, 2007, Pages 63-85

  Green, Ari ^a   Waubant, Emmanuelle ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VITAMIN D;

DISEASE COURSE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; ETHNIC DIFFERENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HERITABILITY; HIGH RISK POPULATION; HUMAN; INCIDENCE; LIGHT EXPOSURE; MULTIPLE SCLEROSIS; PATHOGENESIS; PHENOTYPE; PREVALENCE; RECURRENCE RISK; REVIEW; SEX DIFFERENCE;

EID: 35148868243     PISSN: 10802371     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.CON.0000293641.98116.51     Document Type: Review

References (54)

1. ▶ Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatr Scand Suppl 1960;35(147):132- 147. One of the first publications pertaining to environmental factors.
2. ▶ Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001;286(24):3083-3088. This is a prospective study of Epstein-Barr virus serologies in a large cohort monitored for a long period in which several individuals developed multiple sclerosis (MS). Viral serologies were obtained before MS occurred.
3. ▶ Bachmann S, Kesselring J. Multiple sclerosis and infectious childhood diseases. Neuroepidemiology 1998;17(3):154-160. Work on childhood infections and their relation to MS.
4. ▶ Banwell B, Krupp L, Tellier R, et al. Clinical features and viral serologies in children with multiple sclerosis: results of a multinational cohort study. Lancet Neurol 2007;6(9):773-781.
5. ▶ Baranzini SE, Mousavi P, Rio J, et al. Transcription-based prediction of response to IFNbeta using supervised computational methods. PLoS Biol 2005;3(1):e2. This work has identified several markers that predict response to interferon beta in MS.
6. ▶ Barcellos LF, Oksenberg JR, Begovich AB, et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003;72(3):710-716. This work suggests that the number of DR2 genes an individual has influences susceptibility to MS and disease severity.
7. ▶ Barcellos LF, Oksenberg JR, Green AJ, et al. Multiple Sclerosis Genetics Group. Genetic basis for clinical expression in multiple sclerosis. Brain 2002;125(pt 1):150-158.
8. ▶ Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006;15(18):2813-2824. These results contribute substantially to our understanding of the DRB1 locus and multiple sclerosis (MS) and underscore the importance of using large sample sizes to detect modest genetic effects, particularly in studies of genotype-phenotype relationships.
9. ▶ Beebe GW, Kurtzke JF, Kurland LT, et al. Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the army experience in World War II. Neurology 1967;17(1):1-17. One of the first studies to look at environmental factors in susceptibility to MS.
10. ▶ Brassat D, Azais-Vuillemin C, Yaouanq J, et al; French Multiple Sclerosis Genetics Group. Familial factors influence disability in MS multiplex families. Neurology 1999;52(8):1632-1636. This work suggests that familial factors contribute to disease severity.
11. ▶ Bulman DE, Sadovnick AD, Ebers GC. Age of onset in siblings concordant for multiple sclerosis. Brain 1991;114(pt 2):937-950. Siblings who develop MS may have similar ages of disease onset.
12. ▶ Burwick RM, Ramsay PP, Haines JL, et al. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology 2006;66(9):1373-1383.
13. ▶ Cepok S, Zhou D, Srivastava R, et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005;115(5):1352-1360. A key paper that identifies viral proteins against which the immune system reacts in MS.
14. ▶ Compston A, Coles A. Multiple sclerosis. Lancet 2002;359(9313):1221-1231. Review paper on our current understanding of MS.
15. ▶ Compston A, Confavreux C, Lassman H, et al. McAlpine's multiple sclerosis. Philadelphia: Churchill Livingstone Elsevier, 2005. Comprehensive chapters on epidemiology and genetics of MS.
16. ▶ Compston DA, Vakarelis BN, Paul E, et al. Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain 1986;109(pt 2):325-344.
17. ▶ de Jong BA, Huizinga TW, Zanelli E, et al. Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology 2002;59(4):549-555.
18. ▶ De Stefano N, Cocco E, Lai M, et al. Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis. Ann Neurol 2006;59(4):634-639. This work used brain MRI scans to identify subclinical evidence of MS in families of patients with MS.
19. ▶ Doolittle TH, Myers RH, Lehrich JR, et al. Multiple sclerosis sibling pairs: clustered onset and familial predisposition. Neurology 1990;40(10):1546-1552.
20. ▶ Ebers GC, Sadovnick AD, Risch NJ; Canadian Collaborative Study Group. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995;377(6545):150-151. A critical paper on the genetic basis of MS susceptibility.
21. ▶ Ebers GC, Yee IM, Sadovnick AD, Duquette P; Canadian Collaborative Study Group. Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring. Ann Neurol 2000;48(6):927-931. This work analyzed the risk of MS in spouses and the risk in their children. The low risk for MS spouses and the high risk for offspring support other data indicating that familial risk is genetically determined.
22. ▶ Fazekas F, Strasser-Fuchs S, Kollegger H, et al. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology 2001;57(5):853-857. One of the studies that evaluated the impact of APOE on MS severity.
23. ▶ Freedman DM, Dosemeci M, Alavanja MC. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 2000;57(6):418-421.
24. ▶ Goodin DS, Ebers GC, Johnson KP, et al. The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999;52(9):1737-1745.
25. ▶ Granieri E, Casetta I, Govoni V, et al. The increasing incidence and prevalence of MS in a Sardinian province. Neurology 2000;55(6):842-848. One of the first works to suggest an increase in MS incidence and prevalence.
26. ▶ Haines JL, Terwedow HA, Burgess K, et al; the Multiple Sclerosis Genetics Group. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum Mol Genet 1998;7(8):1229-1234. These results demonstrate that genetic linkage to the MHC can be explained by the HLA-DR2 allelic association. They also indicate that sporadic and familial MS share a common genetic susceptibility. In addition, preliminary calculations suggest that the MHC explains between 17% and 62% of the genetic etiology of MS.
27. ▶ Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006;52(1):61-76. A clear review of the different factors at play in MS.
28. ▶ Hauser SL, Oksenberg JR, Lincoln R, et al; Optic Neuritis Study Group. Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Neurology 2000;54(9):1859-1861. The first study to evaluate the relationship between HLA-DR2 and risk of a second MS event.
29. ▶ Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 2003;49(2):277-300. Information on vitamin D and its impact on the immune system.
30. ▶ Islam T, Gauderman WJ, Cozen W, et al. Differential twin concordance for multiple sclerosis by latitude of birthplace. Ann Neurol 2006;60(1):56-64. Twin study suggesting an interaction between genetic and environmental factors in MS.
31. ▶ Kantarci OH, Barcellos LF, Atkinson EJ, et al. Men transmit MS more often to their children vs women: the Carter effect. Neurology 2006;67(2):305-310.
32. ▶ Kantarci OH, de Andrade M, Weinshenker BG. Identifying disease modifying genes in multiple sclerosis. J Neuroimmunol 2002;123(1-2):144-159.
33. ▶ Kantor R, Bakhanashvili M, Achiron A. A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology 2003;61(2):238-240.
34. ▶ Kelly MA, Cavan DA, Penny MA, et al. The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome. Hum Immunol 1993;37(3):185-191.
35. ▶ Kurtzke JF, Heltberg A. Multiple sclerosis in the Faroe Islands: an epitome. J Clin Epidemiol 2001;54(1):1-22.
36. ▶ Kurtzke JF, Hyllested K, Arbuckle JD, et al. Multiple sclerosis in the Faroe Islands. IV. The lack of a relationship between canine distemper and the epidemics of MS. Acta Neurol Scand 1988;78(6):484-500.
37. ▶ Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005;293(20):2496- 2500.
38. ▶ Ligers A, Dyment DA, Willer CJ; Canadian Collaborative Study Groups. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis. Am J Hum Genet 2001;69(4):900-903.
39. ▶ Marrosu MG, Murru R, Murru MR, et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 2001;10(25):2907-2916.
40. ▶ Martyn CN, Cruddas M, Compston DA. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry 1993;56(2):167-168.
41. ▶ Munch M, Riisom K, Christensen T, et al. The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients? Acta Neurol Scand 1998;97(3):171-174.
42. ▶ Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296(23):2832-2838. This recent paper provides the most robust evidence of a relationship between vitamin D levels and MS risk, but still may be confounded by ethnicity.
43. ▶ Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62(1):60-65.
44. ▶ Oksenberg JR, Baranzini SE, Barcellos LF, Hauser SL. Multiple sclerosis: genomic rewards. J Neuroimmunol 2001;113(2):171-184.
45. ▶ Oksenberg JR, Barcellos LF. Multiple sclerosis genetics: leaving no stone unturned. Genes Immun 2005;6(5):375-387. A good review of the current understanding of MS genetics.
46. ▶ O'Riordan JI, Losseff NA, Phatouros C, et al. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J Neurol Neurosurg Psychiatry 1998;64(3):353-357.
47. ▶ Orton SM, Herrera BM, Yee IM, et al; Canadian Collaborative Study Group. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006;5(11):932-936.
48. ▶ Perron H, Geny C, Laurent A, et al. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989;140(6):551-561.
49. ▶ Reich D, Patterson N, De Jager PL, et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet 2005;37(10):1113-1118.
50. ▶ Riise T. Cluster studies inmultiple sclerosis. Neurology 1997;49(suppl 2):27-32. This paper serves to provide context to all the prior reports of MS clusters.
51. ▶ Sadovnick AD, Ebers GC, Dyment DA, Risch NJ. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996;347(9017):1728-1730.
52. ▶ Sriram U, Barcellos LF, Villoslada P, et al. Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis. Genes Immun 2003;4(2):147-152.
53. ▶ Szklo M, Nieto FJ. Epidemiology - beyond the basics. Sudbury, MA: Jones and Bartlett Publishers, 2007.
54. ▶ Willer CJ, Dyment DA, Sadovnick AD, et al; Canadian Collaborative Study Group. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005;330(7483):120.